| O.1 | Approve Financial Statements | For |
| O.2 | Approve Allocation of Income and Dividends of EUR 1.80 per Share
| For |
| O.3 | Approve Consolidated Financial Statements and Statutory Reports
| For |
| O.4 | Approve Compensation Report of Corporate Officers
| For |
| O.5 | Approve Compensation of Denis Kessler, Chairman and CEO
| For |
| O.6 | Approve Remuneration Policy of Directors
| For |
| O.7 | Approve Remuneration of Directors in the Aggregate Amount of EUR 1.775 Million
| For |
| O.8 | Approve Remuneration Policy of Denis Kessler, Chairman and CEO
| Oppose |
| O.9 | Elect Denis Kessler - Chair (Non Executive) | Oppose |
| O.10 | Elect Claude Tendil - Non-Executive Director | For |
| O.11 | Elect Bruno Pfister - Non-Executive Director | Abstain |
| O.12 | Elect Patricia Lacoste - Non-Executive Director | For |
| O.13 | Elect Laurent Rousseau - Chief Executive | For |
| O.14 | Ratify Appointment of Adrien Couret as Director
| For |
| O.15 | Authorize Repurchase of Up to 10 Percent of Issued Share Capital
| Oppose |
| E.16 | Authorize Capitalization of Reserves of Up to EUR 200 Million for Bonus Issue or Increase in Par Value
| For |
| E.17 | Authorize Issuance of Equity or Equity-Linked Securities with Preemptive Rights up to Aggregate Nominal Amount of EUR 588,347,051
| For |
| E.18 | Authorize Issuance of Equity or Equity-Linked Securities without Preemptive Rights up to Aggregate Nominal Amount of EUR 147,086,759
| Oppose |
| E.19 | Approve Issuance of Equity or Equity-Linked Securities for up to 10 Percent of Issued Capital for Private Placements
| Oppose |
| E.20 | Authorize Capital Increase of Up to EUR 147,086,759 for Future Exchange Offers
| Oppose |
| E.21 | Authorize Capital Increase of up to 10 Percent of Issued Capital for Contributions in Kind
| For |
| E.22 | Authorize Board to Increase Capital in the Event of Additional Demand Related to Delegation Submitted to Shareholder Vote Under Items 17 to 19
| Oppose |
| E.23 | Authorize Issuance of Warrants (Bons 2021 Contingents) without Preemptive Rights Reserved for a Category of Persons up to Aggregate Nominal Amount of EUR 300 Million Re: Contingent Capital
| Oppose |
| E.24 | Authorize Issuance of Warrants (AOF 2021) without Preemptive Rights Reserved for a Category of Persons up to Aggregate Nominal Amount of EUR 300 Million Re: Ancillary Own-Fund
| Oppose |
| E.25 | Authorize Decrease in Share Capital via Cancellation of Repurchased Shares
| For |
| E.26 | Authorize up to 1.5 Million Shares for Use in Stock Option Plans
| Oppose |
| E.27 | Authorize Issuance of up to 3 Million Shares for Use in Restricted Stock Plans
| Oppose |
| E.28 | Approve Issue of Shares for Employee Saving Plan | For |
| E.29 | Set Total Limit for Capital Increase to Result from Issuance Requests Under Items 17-24, 26 and 28 at EUR 770,880,186
| For |
| E.30 | Amend Articles of Bylaws to Comply with Legal Changes
| For |
| E.31 | Amend Article 16 of Bylaws Re: Corporate Governance
| For |
| E.32 | Amend Article 16 of Bylaws Re: Directors' Terms
| For |
| E.33 | Authorize Filing of Required Documents/Other Formalities
| For |
